| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $165.6M | +32.0% |
| SG&A Expense | $58.8M | +40.7% |
| Operating Income | -$224.3M | -34.1% |
| Interest Expense | $1.9M | -37.5% |
| Net Income | -$221.9M | -31.2% |
| EPS (Basic) | -$3.26 | -22.1% |
| EPS (Diluted) | -$3.26 | -22.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $140.5M | -39.6% |
| Short-term Investments | $215.9M | +38.3% |
| Current Assets | $364.1M | -7.1% |
| Total Assets | $551.8M | +11.0% |
| Current Liabilities | $39.2M | +76.7% |
| Total Liabilities | $62.1M | +46.9% |
| Stockholders' Equity | $489.7M | +7.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$178.1M | -47.0% |
| Capital Expenditures | $8.4M | +9.7% |
| Investing Cash Flow | -$69.3M | -467.7% |
| Financing Cash Flow | $155.3M | +312.1% |
| Free Cash Flow | -$186.5M | -44.8% |